Skip to content

A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.

Randomized controlled trial · J Med Food · 2017. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 28850308

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.

Amalraj A, Varma K, Jacob J et al.
J Med Food · 2017

PubMed ID
28850308
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.